CD44 and cancer: In particular, halting of circulating cancer cells occurs in vascular regions where lower shear forces favor the luminal deposition of FN; it is a two-step process, first mediated by CD44 and αvβ3 integrin weak adhesions and then stabilized by α5β1 integrin-dependent high-strength adhesion (Figure 1)27.